Category: Portfolio News

Locus Robotics Recognized in Multiple 2025 Gartner® Hype Cycle™ Reports Across Key Categories

Within these reports, Locus is recognized in several key categories, including Collaborative Aisle Picking Robots (CIPRs), Intralogistics Smart Robots, Gamification in Logistics, and Smart

AvePoint Announces Dual Listing on the Singapore Exchange to Continue Global Expansion

AvePoint (Nasdaq: AVPT, SGX: AVP), the global leader in data security, governance, and resilience, today announced its listing on the Main Board of

Debut Raises $20M to Fast-track AI Ingredient Discovery in Skin Longevity and Grow its Formulation Business in the US and Asia

Debut, the biotech beauty leader, has secured $20M in investment to accelerate the expansion of its proprietary, AI-based ingredient discovery platform to advance

Hydroleap Secures USD 4.75 million in Latest Funding Round to Accelerate Sustainable Water Technologies in APAC

Singapore – July 30, 2025 – Hydroleap, a pioneering company in sustainable water treatment technologies, has successfully raised an additional USD 4.75 million in

Augmentus Raises $11M to Scale Physical AI for High-Mix, Complex Robotic Surface Finishing and Welding

Augmentus, the developer of an intelligent no-code robotics solution, announced today that it has raised USD $11 million (SGD $14 million) in a Series

Tacta Systems Announces $75 million in Funding to Bring Dextrous Intelligence to Robot

Tacta Systems, a robotics company developing dextrous intelligence to give robots human-level tactile skills and spatial awareness, today announced $75 million in funding

Multiplier Holdings Launches With $27.5 Million in Funding to Accelerate the AI Journey for Professional Services Firms

New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform.

Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line to Advance ATX101 and its Ultra-Sustained Pain Platform for Post-Surgical Pain Management

New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform.

Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy

New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform.

Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy

Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, today announced the successful completion of US$45 million Series B